Literature DB >> 23241293

[Consensus guidelines for the management of upper respiratory tract infections].

Gustavo Lopardo1, Aníbal Calmaggi, Liliana Clara, Gabriel Levy Hara, Analía Mykietiuk, Daniel Pryluka, Silvina Ruvinsky, Claudia Vujacich, Diego Yahni, Elizabeth Bogdanowicz, Manuel Klein, María J López Furst, Claudia Pensotti, María J Rial, Pablo Scapellato.   

Abstract

Upper respiratory tract infections are the most common source of antibiotic prescriptions. Acute pharyngitis is caused mainly by viruses, viral cases can be distinguished from acute streptococcal pharyngitis using Centor clinical epidemiological criteria, by rapid antigen tests or throat culture. Treatment of choice for streptococcal infection is penicillin V given in two daily doses. In children, acute otitis media (AOM) is the infection for which antibiotics are most often prescribed. Predominant causative pathogens include Streptococcus pneumoniae, Haemophilus influenzae non-type b and Moraxella catarrhalis. Diagnosis is based on history, physical examination and otoscopic exam. Antibiotic treatment should be initiated promptly in all children<2 years of age, and in older children presenting bilateral AOM, otorrhoea, co-morbidities or severe illness. In Argentina, amoxicillin is the drug of choice given the low penicillin resistance rates for S. pneumoniae. In children who fail amoxicillin therapy, amoxicillin/clavulanate provides better coverage against beta-lactamase producing H. influenzae and M. catarrhalis. Rhinosinusitis is caused mainly by viruses, secondary bacterial complication occurs in less than 5% of cases. Diagnosis is based on physical examination and additional studies are not usually required. Acute bacterial sinusitis is caused by the same pathogens that cause AOM and amoxicillin is the drug of choice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241293

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  2 in total

1.  Non-culturable bioaerosols in indoor settings: Impact on health and molecular approaches for detection.

Authors:  Pascale Blais-Lecours; Phillipa Perrott; Caroline Duchaine
Journal:  Atmos Environ (1994)       Date:  2015-03-20       Impact factor: 4.798

2.  Effectiveness and safety of Danmu extract syrup for acute upper respiratory tract infection in children: A real-world, prospective cohort study.

Authors:  Linan Zeng; Hailong Li; Chuan Zhang; Deying Kang; Guanjian Liu; Xihong Li; Lina Chen; Min Zeng; Liang Huang; Peipei Xu; Shiyin Feng; Qin Yu; Hanmin Liu; Lingli Zhang
Journal:  J Evid Based Med       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.